A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could lead to individuals administering products of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.
Platform Reaction and Content Removal
According to TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service safe and investing in strengthening compliance measures.
Online Marketplace Operations
Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of joining one community, a seller posted contact information, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Costs
Within these groups, messages display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly significant medical dangers”.
